+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses



Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses



Journal of Veterinary Pharmacology and Therapeutics 37(1): 35-42



In most species, large variations in body size necessitate dose adjustments based on an allometric function of body weight. Despite the substantial disparity in body size between miniature horses and light-breed horses, there are no studies investigating appropriate dosing of any veterinary drug in miniature horses. The purpose of this study was to determine whether miniature horses should receive a different dosage of flunixin meglumine than that used typically in light-breed horses. A standard dose of flunixin meglumine was administered intravenously to eight horses of each breed, and three-compartmental analysis was used to compare pharmacokinetic parameters between breed groups. The total body clearance of flunixin was 0.97 ± 0.30 mL/min/kg in miniature horses and 1.04 ± 0.27 mL/min/kg in quarter horses. There were no significant differences between miniature horses and quarter horses in total body clearance, the terminal elimination rate, area under the plasma concentration versus time curve, apparent volume of distribution at steady-state or the volume of the central compartment for flunixin (P > 0.05). Therefore, flunixin meglumine may be administered to miniature horses at the same dosage as is used in light-breed horses.

(PDF emailed within 0-6 h: $19.90)

Accession: 036886672

Download citation: RISBibTeXText

PMID: 23659780

DOI: 10.1111/jvp.12056


Related references

Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses. American Journal of Veterinary Research 60(11): 1441-1444, 1999

Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. American Journal of Veterinary Research 46(12): 2474-2479, 1985

Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics 38(4): 313-320, 2016

Disposition of flunixin after intramuscular administration of flunixin meglumine to horses. Journal of Veterinary Pharmacology & Therapeutics 20(4): 330-332, 1997

Effect of flunixin meglumine on prostanoids in horses with mechanical ileus. Pratique Veterinaire Equine 28(4): 261-267, 1996

Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. American Journal of Veterinary Research 58(11): 1291-1299, 1997

Effect of flunixin meglumine on plasma prostanoid concentrations in horses with colic in the perioperative period. Dtw. Deutsche Tierarztliche Wochenschrift 104(9): 365-368, 1997

Reference values for amino acids and acylcarnitines in peripheral blood in Quarter horses and American Miniature horses. Acta Veterinaria Scandinavica 57(): 62-62, 2016

Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery. American Journal of Veterinary Research 76(3): 208-215, 2015

Flunixin meglumine (Banamine): use in horses. Annali della Facolta di medicina veterinaria Universita di Parmaub 1982) 1(1): 91-98, 1982

Disposition and excretion of flunixin meglumine in horses. American Journal of Veterinary Research 49(11): 1894-1898, 1988

Distribution of flunixin meglumine and firocoxib into aqueous humor of horses. Journal of Veterinary Internal Medicine 25(5): 1127-1133, 2012

Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test. Veterinary Therapeutics 3(1): 37-48, 2002

Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. Equine Veterinary Journal. Supplement 2012(40): 12-17, 2012

Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. Journal of the American Veterinary Medical Association 202(1): 71-77, 1993